How to Stop Taking Antidepressants Safely

Why should I not stop an antidepressant abruptly?

Antidepressants — especially SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) — change how your brain regulates certain chemical messengers. When you stop suddenly, your brain has not had time to readjust, which can produce what clinicians call antidepressant discontinuation syndrome 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Antidepressant discontinuation syndrome — its symptoms (brain zaps, dizziness, nausea, flu-like feelings), the role of half-life in taper difficulty, the distinction from relapse, and the importance of gradual tapering.

Common symptoms include dizziness, electric-shock-like feelings in the head (sometimes called "brain zaps"), nausea, irritability, vivid dreams, and flu-like fatigue. These are not signs of addiction — they are a physiological adjustment. A slow taper lets your brain adapt gradually and usually prevents or greatly reduces these symptoms 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Antidepressant discontinuation syndrome — its symptoms (brain zaps, dizziness, nausea, flu-like feelings), the role of half-life in taper difficulty, the distinction from relapse, and the importance of gradual tapering.

Some antidepressants (such as paroxetine and venlafaxine) carry a higher risk of intense discontinuation symptoms due to their shorter half-life. Others (such as fluoxetine) tend to taper more smoothly. Your clinician knows which category applies to your medication.

What does a safe antidepressant taper look like?

There is no single universal taper schedule — clinicians individualize it based on your medication, dose, duration of treatment, and reason for stopping. In general, the dose is reduced in small steps with time between each step to confirm you are tolerating the change.

Your reason for stopping matters to the plan 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Antidepressant discontinuation syndrome — its symptoms (brain zaps, dizziness, nausea, flu-like feelings), the role of half-life in taper difficulty, the distinction from relapse, and the importance of gradual tapering: - Stopping after successful treatment — typically requires a longer taper; relapse risk is worth monitoring closely. - Switching to a different medication — the taper and transition timing depend on the new medication's mechanism. - Stopping due to side effects — may need a different pace depending on which side effects are present. - Cost or access issues — a clinician can often identify a generic or lower-cost alternative before you stop entirely.

Longer treatment duration typically calls for a longer, more gradual taper.

What should I watch for during a taper?

Keep a brief daily mood and symptom log — even just a few words on your phone. Note sleep quality, irritability, appetite, and any physical symptoms. This record is genuinely useful: it helps your clinician tell the difference between:

• A discontinuation symptom — usually physical and brief, appearing within days of a dose reduction
• A return of the original condition — typically mood-based and building over days to weeks
• A new symptom — that needs its own attention

If symptoms appear between dose reductions, it is reasonable to pause the taper and discuss with your clinician rather than pushing through 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Antidepressant discontinuation syndrome — its symptoms (brain zaps, dizziness, nausea, flu-like feelings), the role of half-life in taper difficulty, the distinction from relapse, and the importance of gradual tapering. Standardized tools such as the PHQ-9 can be used before and during a taper to track mood objectively 2Ref 2Kroenke K, Spitzer RL, Williams JBW (2001).The PHQ-9: Validity of a Brief Depression Severity Measure.The PHQ-9 is a validated tool to establish mood baseline before and during a taper so changes can be measured objectively.

When is it not a good time to taper?

Timing matters. Avoid starting a taper during a high-stress life period — a major job change, a recent loss, a relationship crisis — if you can help it. A stable window makes a successful taper more likely.

Also let your clinician know if you are pregnant or planning to become pregnant. Untreated depression during pregnancy carries its own risks, so the decision to taper involves weighing the risks of both the medication and the untreated condition — a conversation that requires specialist input.

Having an active therapist (especially one using CBT 3Ref 3Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A (2012).The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.CBT during a taper provides skills for managing symptoms and improves outcomes — evidence base for concurrent therapy) during a taper significantly improves outcomes and provides a safety net if symptoms return.

What factors shape how your taper is planned?

Length of treatment. People who have been on an antidepressant for years generally need a longer, slower taper than those who have been on it for a few months.

Specific medication. Some antidepressants (like paroxetine and venlafaxine) are associated with more intense discontinuation symptoms; others (like fluoxetine) taper more smoothly due to a longer half-life 1Ref 1Warner CH, Bobo W, Warner C, Reid S, Rachal J (2006).Antidepressant Discontinuation Syndrome.Antidepressant discontinuation syndrome — its symptoms (brain zaps, dizziness, nausea, flu-like feelings), the role of half-life in taper difficulty, the distinction from relapse, and the importance of gradual tapering.

Pregnancy or breastfeeding. The decision becomes more complex — this requires a specialist-level conversation.

History of multiple depressive episodes. Guidelines generally suggest longer maintenance treatment for people who have had recurrent episodes; the conversation about stopping is different.

Concurrent therapy. An active therapist during a taper significantly improves outcomes and provides a safety net if symptoms return.